Impact of inappropriate drug use among hospitalized older adults
- 608 Downloads
Criteria for inappropriate drug use developed by Beers have been widely used in drug utilization reviews as the basis for educational materials and to assess the quality of prescribing. However, there is inconclusive evidence that these criteria can impact on patient outcomes. The objective of this study was to evaluate the impact of inappropriate drug use on all-cause mortality, adverse drug reactions (ADRs) and length of stay among in-hospital patients.
We performed a retrospective, cohort study on 5,152 patients aged 65 years or older admitted to 81 hospitals in Italy between 1997 and 1998. Inappropriate drug use was defined by 2003 Beers criteria. Outcomes of the study were: (a) in-hospital mortality; (b) incidence of ADR occurring during hospital stay; (c) length of hospital stay 13 days or more.
The mean age of 5,152 participants was 78.8 years (standard deviation = 8.4 years), and 2,463 (47.8%) were men. During hospital stay, 1,475 (28.6% of the study sample) patients received one or more inappropriate drugs. After adjusting for potential confounders, use of inappropriate drugs was not associated significantly with either mortality [odds ratio (OR) 1.05; 95% confidence intervals (CI): 0.75–1.48], ADR (OR 1.20; 95% CI: 0.89–1.61) or length of stay 13 days or more (OR 1.09; 95% CI: 0.95–1.25).
This study did not show any significant effect of inappropriate drug use defined by Beers 2003 criteria on health outcomes among hospitalized older adults. Further studies conducted in different settings, using additional health outcomes and alternate measures of inappropriate drug use, are needed.
KeywordsInappropriate drug use Older adults Mortality Adverse drug reactions In-hospital
The GIFA study was partially supported by a grant from the National Research Council (n. 94000402) and by Neopharmed.
- 1.Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27:832–840Google Scholar
- 3.Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J (2001)Analysis of the direct cost of adverse drug reactions in hospitalised patients. Eur J Clin Pharmacol 56:935–941Google Scholar
- 16.Onder G, Landi F, Cesari M, Gambassi G, Carbonin P, Bernabei R (2003) Investigators of the GIFA Study. Inappropriate medication use among hospitalized older adults in Italy: results from the Italian Group of Pharmacoepidemiology in the Elderly. Eur J Clin Pharmacol 59:157–162Google Scholar
- 20.Fick DM, Waller JL, Maclean JR, Vander Heuvel R, Tadlock JG, Gottlieb M, Cangialose CB (2001) Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilization. J Manage Care Pharm 7:407–413Google Scholar
- 23.Onder G, Pedone C, Gambassi G, Landi F, Cesari M, Bernabei R (2001) Investigators of the GIFA Study. Treatment of osteoporosis among older adults discharged from hospital in Italy. Eur J Clin Pharmacol 57:599–604Google Scholar
- 27.PHS-HCFA (1980) International classification of diseases, 9th rev. Public Health Service-Health Care Financing Administration, Washington DCGoogle Scholar
- 30.World Health Organization (1986) International drug monitoring: the role of the hospital. WHO Tech Rep Ser No 425Google Scholar
- 32.Hosmer DW and Lemeshow S (2000) Applied logistic regression, 2nd edn. Wiley, New YorkGoogle Scholar
- 35.Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, Schroll M, Onder G, Sørbye LW, Wagner C, Reissigová J, Bernabei R, for AdHOC project research group (2005) Potentially inappropriate medication use among home care elderly patients in Europe. JAMA 293(11):1348–1358CrossRefPubMedGoogle Scholar
- 38.Onder G, Gambassi G, Scales CJ, Cesari M, Vedova CD, Landi F, Bernabei R (2002) Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 58:371–377Google Scholar